![BX-471 - CAS# 217645-70-0 60310 7-tetrabromo-1H-benzo[d][1](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/BX-471__ZK-811752__structure.gif?v=1742668332)
Pay in 4 interest-free payments of $13.00 Learn more
Ships within 48 hours · Estimated delivery Sep 21 - Sep 26
7-tetrabromo-1H-benzo[d][1
SCR7 was used at 1 µM final concentration in CRISPR editing
SR9243 kills cancer cells by inhibiting lipid production and the Warburg effect
Curr Med Res Opin
randomized
BX-471 - CAS# 217645-70-0 60310 7-tetrabromo-1H-benzo[d][1BX 471, CAS No. 217645 70 0, also known as ZK 811752, is a potent, selective non peptide CCR1 antagonist (Ki = 1 nM for human CCR1). BX 471 exhibits 250 fold selectivity for CCR1 over CCR2, CCR5 and CXCR4. BX 471 was developed Berlex and its parent company, Schering AG. BX 471 is the lead in a series of non peptide chemokine receptor 1 (CCR1) antagonists, for the potential treatment of autoimmune diseases, in particular multiple sclerosis (MS). In
US$ 196.50
US$ 596.00
US$ 506.50
US$ 250.00